Christopher D. Payne net worth and biography

Christopher Payne Biography and Net Worth

Director of Hims & Hers Health

Christopher Payne has been a member of our Board of Directors since March 2024. He is a proven leader with more than three decades of software and technology experience. He previously served as the President and Chief Operating Officer of DoorDash from 2016 to 2023. Prior to his time at DoorDash, he served as the CEO of Tinder. He also served as Senior Vice President at eBay after he sold his company, Positronic, to the online retailer in 2008. Mr. Payne has also held leadership positions at Microsoft and Amazon, and currently serves on the board of directors of Gogo. He holds a B.A. in US History from Dartmouth College.

What is Christopher D. Payne's net worth?: The estimated net worth of Christopher D. Payne is at least $1.06 million as of June 13th, 2025. Mr. Payne owns 26,500 shares of Hims & Hers Health stock worth more than $1,061,060 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Payne may own. Learn More about Christopher D. Payne's net worth.
How do I contact Christopher D. Payne?: The corporate mailing address for Mr. Payne and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at [email protected]. Learn More on Christopher D. Payne's contact information.
Has Christopher D. Payne been buying or selling shares of Hims & Hers Health?: Christopher D. Payne has not been actively trading shares of Hims & Hers Health in the last ninety days. Most recently, on Wednesday, May 22nd, Christopher D. Payne bought 110,000 shares of Hims & Hers Health stock. The stock was acquired at an average cost of $17.74 per share, with a total value of $1,951,763.00. Following the completion of the transaction, the director now directly owns 110,000 shares of the company's stock, valued at $1,951,763. Learn More on Christopher D. Payne's trading history.
Who are Hims & Hers Health's active insiders?: Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Irene Becklund (Insider), Irene Becklund (Insider), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Anja Manuel (Director), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.
Are insiders buying or selling shares of Hims & Hers Health?: In the last year, insiders at the sold shares 94 times. They sold a total of 3,695,388 shares worth more than $166,986,368.93. The most recent insider tranaction occured on November, 17th when CFO Oluyemi Okupe sold 23,187 shares worth more than $853,513.47. Insiders at Hims & Hers Health own 13.7% of the company. Learn More about insider trades at Hims & Hers Health.
Information on this page was last updated on 11/17/2025.

Christopher D. Payne Insider Trading History at Hims & Hers Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/22/2024	Buy	110,000	$17.74	$1,951,763.00	110,000

Christopher D. Payne Buying and Selling Activity at Hims & Hers Health

Hims & Hers Health Company Overview

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Today's Range

Now: $40.04

$37.72

$40.46

50 Day Range

MA: $46.14

$33.64

$62.79

2 Week Range

Now: $40.04

$23.97

$72.98

Volume

24,652,590 shs

Average Volume

21,227,630 shs

Market Capitalization

$9.12 billion

P/E Ratio

74.15

Dividend Yield

N/A

Beta

2.41